Manfred Gossen

Title: Manfred Gossen: Innovator in Nucleic Acid Technology

Introduction

Manfred Gossen is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of nucleic acid technology, particularly in the development of methods to inhibit gene expression. His innovative work has implications for various applications in biotechnology and medicine.

Latest Patents

Gossen holds a patent for a method titled "Means for inhibiting the expression of Orc-1." This invention involves a nucleic acid molecule with a double-stranded structure. The first strand of this structure is designed to be at least partially complementary to a target nucleic acid, while the second strand complements the first. The patent details specific nucleotide sequences that are crucial for the functionality of this invention.

Career Highlights

Throughout his career, Gossen has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Silence Therapeutics GmbH and Tet Systems GmbH & Co. KG. His work in these organizations has allowed him to advance his research and contribute to innovative solutions in the field.

Collaborations

Gossen has collaborated with various professionals in his field, including Ansgar Santel. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Manfred Gossen's contributions to nucleic acid technology and his innovative patent demonstrate his commitment to advancing scientific knowledge. His work continues to influence the biotechnology landscape, showcasing the importance of innovation in addressing complex biological challenges.